Covid-19 vaccine development sees unparalleled progress

At least seven teams are developing vaccines using the Sars-CoV-2 virus in a weakened or inactivated form, such as those against measles and polio. Sinovac Biotech in Beijing is testing an inactivated form of Sars-CoV-2 in humans.